Cargando…

The Impact of Hypertension and Atrial Fibrillation on Cognitive Decline and Subclinical Atherosclerosis

Background: Assessment of cognitive impairment and the presence of subclinical atherosclerosis are very important especially in patients with cardiovascular risk factors. Methods: We included 155 hypertensive patients (84 with AF versus 71 without AF) to identify the premature cognitive impairment,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Militaru, Marius, Rachieru, Ciprian, Lighezan, Daniel Florin, Militaru, Anda Gabriela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228320/ https://www.ncbi.nlm.nih.gov/pubmed/34204086 http://dx.doi.org/10.3390/brainsci11060752

Ejemplares similares

Prevalence of Cardio-Embolic Brain Complications in Permanent and Paroxysmal Atrial Fibrillation Patients
por: Rosca, Ciprian Ilie, et al.
Publicado: (2023)

Benefits of prescribing low-dose digoxin in atrial fibrillation
por: Rosca, Ciprian Ilie, et al.
Publicado: (2021)

Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
por: Nakase, Taizen, et al.
Publicado: (2023)

Atrial Fibrillation Recurrence Predictors after Conversion to Sinus Rhythm
por: MILITARU, C., et al.
Publicado: (2014)

Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View
por: Rosca, Ciprian Ilie, et al.
Publicado: (2023)

Association of subclinical atherosclerosis and cognitive decline: a community-based cross-sectional study
por: Lu, Yao, et al.
Publicado: (2022)

Future Perspectives to Improve CHA(2)DS(2)VASc Score: The Role of Left Atrium Remodelling, Inflammation and Genetics in Anticoagulation of Atrial Fibrillation
por: Rachieru, Ciprian, et al.
Publicado: (2023)

Impact of anticoagulation therapy on the cognitive decline and dementia in patients with non‐valvular atrial fibrillation (cognitive decline and dementia in patients with non‐valvular atrial fibrillation [CAF] trial)
por: Bunch, Thomas Jared, et al.
Publicado: (2022)

Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
por: Ding, Mozhu, et al.
Publicado: (2018)

Brain lesions and cognitive decline in patients with atrial fibrillation
por: Hennings, E, et al.
Publicado: (2023)

Migraine without Aura and Subclinical Atherosclerosis in Young Females: Is Gut Microbiota to Blame?
por: Georgescu, Doina, et al.
Publicado: (2019)

Subclinical Measures of Peripheral Atherosclerosis and the Risk of New‐Onset Atrial Fibrillation in the General Population: the Rotterdam Study
por: Geurts, Sven, et al.
Publicado: (2021)

Atrial fibrillation as a risk factor for cognitive decline and dementia
por: Singh-Manoux, Archana, et al.
Publicado: (2017)

Association of Atrial Fibrillation With Cognitive Decline and Dementia Over 20 Years: The ARIC‐NCS (Atherosclerosis Risk in Communities Neurocognitive Study)
por: Chen, Lin Y., et al.
Publicado: (2018)

Subclinical atrial fibrillation: when to give NAO?
por: Patti, Giuseppe, et al.
Publicado: (2020)

Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism
por: Gencer, Baris, et al.
Publicado: (2022)

Association of Left Atrial Enlargement and Atrial Fibrillation With Cognitive Function and Decline: The ARIC‐NCS
por: Zhang, Michael J., et al.
Publicado: (2019)

Impact of hypertension on various markers of subclinical atherosclerosis in early type 2 diabetes
por: Alatab, Sudabeh, et al.
Publicado: (2014)

Subclinical postoperative atrial fibrillation: a randomized trial
por: Sabbag, Avi, et al.
Publicado: (2023)

Impact of Hypertension on Cognitive Decline and Dementia
por: Naing, Han Lin, et al.
Publicado: (2020)

Subclinical Thyroid Dysfunction and Cognitive Decline in Old Age
por: Wijsman, Liselotte W., et al.
Publicado: (2013)

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline
por: Merluzzi, Andrew P., et al.
Publicado: (2019)

Anticoagulation in atrial fibrillation and cognitive decline: A systematic review and meta-analysis
por: Zeng, Decai, et al.
Publicado: (2019)

Clinical Impact of Atrial Fibrillation in Patients with Pulmonary Hypertension
por: Rottlaender, Dennis, et al.
Publicado: (2012)

Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019)

Prevalence and predictors of subclinical atrial fibrillation in hospitalized older adults
por: Spannella, Francesco, et al.
Publicado: (2021)

Device-Detected Subclinical Atrial Fibrillation as Fire Under the Ashes
por: Park, Seung-Jung
Publicado: (2023)

The Impact of Atrial Fibrillation on All Heart Chambers Remodeling and Function in Patients with Dilated Cardiomyopathy—A Two- and Three-Dimensional Echocardiography Study
por: Iovănescu, Maria L., et al.
Publicado: (2023)

Subclinical carotid artery atherosclerosis and cognitive function in older adults
por: Lin, Felice, et al.
Publicado: (2022)

Incidence and risk factors of post-operative cognitive decline after ablation for atrial fibrillation
por: Zhang, Jing, et al.
Publicado: (2021)

Subclinical persistent atrial fibrillation in left atrium behind the ectopic atrial rhythm on electrocardiogram
por: Mizutani, Yoshiaki, et al.
Publicado: (2023)

Declined ELABELA plasma levels in hypertension patients with atrial fibrillation: a case control study
por: Ma, Zheng, et al.
Publicado: (2021)

Associations of subclinical heart failure and atrial fibrillation with mild cognitive impairment: a cross-sectional study in a subclinical heart failure screening programme
por: Potter, Elizabeth L, et al.
Publicado: (2021)

Impact of Atrial Fibrillation on Healthcare Utilization in the Community: The Atherosclerosis Risk in Communities Study
por: Bengtson, Lindsay G. S., et al.
Publicado: (2014)

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation
por: Wijesurendra, R, et al.
Publicado: (2023)

Association and impact of hypertension defined using the 2017 AHA/ACC guidelines on the risk of atrial fibrillation in The Atherosclerosis Risk in Communities study
por: Rattani, Anas, et al.
Publicado: (2019)

Atrial Fibrillation: More Than a Subclinical Problem in Patients on Hemodialysis
por: Law, Mandy M., et al.
Publicado: (2021)

Electrocardiographic markers of subclinical atrial fibrillation detected by implantable loop recorder
por: Xing, L Y, et al.
Publicado: (2023)

Increased left atrial pressure in non-heart failure patients with subclinical hypothyroidism and atrial fibrillation
por: Sairaku, Akinori, et al.
Publicado: (2016)

Distinct atrial remodeling in patients with subclinical atrial fibrillation: Lessons from computed tomographic images
por: Huang, Sung‐Hao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g7m05jsh43b8b7m9diuj47mfj3